AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ARIPIPRAZOLE

73 registrations across 9 African markets— 59 active

Markets with ARIPIPRAZOLE

🇿🇦South Africa
45 registrations
35 active
🇿🇼Zimbabwe
10 registrations
10 active
🇳🇬Nigeria
5 registrations
5 active
🇹🇳Tunisia
4 registrations
0 active
🇿🇲Zambia
3 registrations
3 active
🇹🇿Tanzania
2 registrations
2 active
🇲🇦Morocco
2 registrations
2 active
🇰🇪Kenya
1 registration
1 active
🇸🇳Senegal
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
ARIPITAS-30mg
Tablet
🇰🇪KenyaIntas Pharmaceuticals LtdactiveJul 2031
Thryve 15
Tablet Uncoated
🇿🇲ZambiaInnovata Pharmaceuticals (Pty) LtdactiveApr 2031
Thryve 10
Tablet Uncoated
🇿🇲ZambiaInnovata Pharmaceuticals (Pty) LtdactiveFeb 2031
Thryve 5
Tablet Uncoated
🇿🇲ZambiaInnovata Pharmaceuticals (Pty) LtdactiveFeb 2031
Praxal-30 Tablet_
Tablet
🇳🇬NigeriaPharmacy Plus LtdactiveAug 2030
ARIPTAS OD 10
TABLET; ORAL
🇿🇼ZimbabweINTAS PHARMACEUTICAL LIMITEDactiveJun 2030
ARIPITAS OD 15
TABLET; ORAL
🇿🇼ZimbabweINTAS PHARMACEUTICAL LIMITEDactiveJun 2030
Praxal-5 Tablet_
Tablet
🇳🇬NigeriaPharmacy Plus LtdactiveJun 2030
ABIPIP 10🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMar 2030
ABIPIP 5🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMar 2030
ABIPIP 15🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMar 2030
ABIPIP 30🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMar 2030
ARIPIPRAZOLE 5 mg ACCORD🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2029
ARIPIPRAZOLE 10 mg ACCORD🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2029
ARIPIPRAZOLE 30 mg ACCORD🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2029
ARIPIPRAZOLE 15 mg ACCORD🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2029
ARIPIPRAZOLE 15 UNICORN🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJul 2029
ARIPIPRAZOLE 5 UNICORN🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJul 2029
ARIPIPRAZOLE 30 UNICORN🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdunknownJul 2029
ARIPIPRAZOLE 10 UNICORN🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJul 2029
Aqeud 10 Tablets
Tablet
🇳🇬NigeriaLeotetra Healthcare LtdactiveJan 2029
ARIP MT15
TABLET; ORAL
🇿🇼ZimbabweTORRENT PHARMACEUTICALSactiveNov 2028
ARIP MT10
TABLET; ORAL
🇿🇼ZimbabweTORRENT PHARMACEUTICALSactiveNov 2028
APIZE 5 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
APIZE 10 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPIPRAZOLE 10 mg ALKEM🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPIPRAZOLE 5 mg ALKEM🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
APIZE 15 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
APIZE 30 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPHRENZ 5 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPHRENZ 15 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPHRENZ 30 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPIPRAZOLE 15 mg ALKEM🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPIPRAZOLE 30 mg ALKEM🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
ARIPHRENZ 10 mg🇿🇦South AfricaAscend Laboratories (Pty) LtdactiveFeb 2028
THRYVE 10
TABLET; ORAL
🇿🇼ZimbabweNEW AVAKASH INTERNATIONALactiveDec 2027
ARIPIPRAZOLE
TABLET, COATED; ORAL
🇿🇼ZimbabweKARLADE GLOBAL DMCCactiveDec 2027
ARIPIPRAZOLE
TABLET, COATED; ORAL
🇿🇼ZimbabweKARLADE GLOBAL DMCCactiveDec 2027
ARIPRIPAZOLE
TABLET, COATED; ORAL
🇿🇼ZimbabweKARLADE GLOBAL DMCCactiveDec 2027
THRYVE 15
TABLET; ORAL
🇿🇼ZimbabweNEW AVAKASH INTERNATIONALactiveDec 2027
THRYVE 5
TABLET, COATED; ORAL
🇿🇼ZimbabweNEW AVAKASH INTERNATIONALactiveDec 2027
Debixa-10 Tablets
Tablet
🇳🇬NigeriaBio-Generics Nigeria LimitedactiveDec 2026
Tenify Tablets
Tablet
🇳🇬NigeriaMaz-Med Pharmaceutical LtdactiveDec 2025
ARIPIPRAZOLE CIPLA 15🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedSept 2024
ARIPIPRAZOLE CIPLA 5🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedSept 2024
ARIPIPRAZOLE CIPLA 10🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedSept 2024
ARIPIPRAZOLE CIPLA 30🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJun 2024
ARIPIPRAZOLE SANDOZ 10🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedSept 2023
ARIPIPRAZOLE SANDOZ 15🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedSept 2023
ARIPIPRAZOLE SANDOZ 20🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedSept 2023

Showing 50 of 73 registrations. Sign up free to search and export all.

ARIPIPRAZOLE in Africa — Regulatory Overview

ARIPIPRAZOLE is registered across 9 African markets with 73 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Nigeria, Tunisia and 5 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 73 registrations, 59 (81%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.